B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway. Oncogene 34, 1207-1219. doi: 10.1038/onc.2014.43T-SWu, C-TTan, C-CChang, B-RLin, W-TLai, S-TChen, MYen-Ping Kuo, C-LRau, F-SJaw, H-HChang. (2014) B-cell lymphoma/...
diffuse large- B-cell lymphoma Jie Sun*, Liang Cheng*, Hongbo Shi*, Zhaoyue Zhang, Hengqiang Zhao, Zhenzhen Wang & Meng Zhou Long non-coding RNAs (lncRNAs) represent an emerging layer of cancer biology and have been implicated in the development and progression of cancers. ...
The prognosis depends on the histologic type, stage, and treatment. Next: Background What to Read Next on Medscape Related Conditions and Diseases Diffuse Large B-Cell Lymphoma (Non-Hodgkin Lymphoma) Staging Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse Large B-Cell Lymphoma (Non-Hodgkin ...
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: results from a monoinstitutional cohort analysis of long-term ...
In contrast to many other B-cell lymphoma entities, there are no genetic aberrations that are common to all CLL patients. Several recurrent aberrations have been characterized, where the most frequent are deletion of 13q14 (50–55%), deletion of 11q22-23 (12–18%),trisomy 12(11–16%) ...
[Key words]Epstein-Barr virus; Non-Hodgkin’s lymphoma; Diffuse large B-cell lymphoma; Immunotherapy; Targeted therapy EB病毒(Epstein-Barr virus,EBV)属于γ疱疹病毒亚科[1],其规范名称是人类疱疹病毒4型(human herpesvirus 4,HHV-4),在1...
【Abstract】DiffuselargeB-celllymphoma(DLBCL)isthemostcommontypeofnon-Hodgkin’slymphoma.Asitsvarietyofclinical,morphologicalandgeneticcharacters,theclassificationandprognosisarestilldebated.Tumormakers(TM)aresubstanceusuallyproteins,thatareproducedbythebodyinresponsetocancergrowthorbythecancertissueitself.Thisarticleai...
B-cell malignancies, such as the B-cell subtype of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, are significant contributors to cancer mortality. The response of B-cell malignancies to various forms of treatment is mixed. Tra... DM Goldenberg - US 被引量: 495发表: 1998年 Signific...
初治弥漫性大B细胞淋巴瘤(diffuse large B-cell Lymphoma, DLBCL)患者的生存率存在很大的异质性。目前使用最广泛的三个评分系统包括国际预后指数(International Prognostic Index, IPI)、改良IPI(revised IPI, R-IPI)及美国国立综合癌症...
Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics. Int J Hematol. 2006;83:331–6. Article PubMed Google Scholar Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature....